Allyl 2,3-di-O-benzyl-beta-D-glucopyranoside(CAS: 84218-68-8)

Allyl 2,3-di-O-benzyl-beta-D-glucopyranoside (CAS: 84218-68-8) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and may require FDA/EPA registration for commercial use in the USA. Compliance with specific local and international regulations is essential for its safe handling and distribution.

Yes, there are alternatives such as other allyl glycosides and related glycosylated compounds. Common substitutes include benzylated derivatives of other sugars or different allyl glycosides. These alternatives can be used based on the specific requirements of the synthesis pathway and the desired end product.

The market for Allyl 2,3-di-O-benzyl-beta-D-glucopyranoside (CAS: 84218-68-8) is growing due to increasing demand in pharmaceuticals and biotechnology. Research trends focus on its use in drug delivery systems and as a building block for complex glycosidic structures. Market trends indicate rising prices and increased interest in sustainable synthesis methods.

Waste containing Allyl 2,3-di-O-benzyl-beta-D-glucopyranoside (CAS: 84218-68-8) should be collected in appropriate containers and disposed of via professional waste disposal services. Incineration is a common method, but ensure that it complies with local environmental regulations. Always follow safety guidelines to prevent environmental contamination and ensure worker safety.